109 related articles for article (PubMed ID: 7879626)
1. Functional and phenotypic analysis of T-lymphocytes in laryngeal carcinoma.
González FM; Vargas JA; Gea-Banacloche JC; García JR; Berrocal E; Gorriz C; Durántez A
Acta Otolaryngol; 1994 Nov; 114(6):663-8. PubMed ID: 7879626
[TBL] [Abstract][Full Text] [Related]
2. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
6. [Rosette-forming capacity of lymphocytes and lymphoid infiltration of the tumor stroma as indicators of immunologic homeostasis in patients with laryngeal cancer].
Ladniuk PB; Shargorodskaia AZ; Dorosevich AE
Vestn Otorinolaringol; 1983; (3):46-8. PubMed ID: 6603046
[No Abstract] [Full Text] [Related]
7. [Morphological and biological features of squamous cell carcinoma of the larynx].
Alferov VS; Akhundov AA; Pavlovskaia AI; Nikolaeva TG; Azizian RI; Zak KM; Rotobel'skaia LE
Vestn Otorinolaringol; 1995; (6):27-31. PubMed ID: 8553510
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of DNA content in laryngeal squamous cell carcinoma in relation to histopathological variables.
Ladika-Davidovic B; Coric M; Bura M; Brcic L; Kusic Z; Seiwerth S
Acta Otolaryngol; 2009 Jul; 129(7):768-73. PubMed ID: 18766495
[TBL] [Abstract][Full Text] [Related]
9. Expression of PTEN protein in patients with laryngeal squamous cell carcinoma.
Guney K; Ozbilim G; Derin AT; Cetin S
Auris Nasus Larynx; 2007 Dec; 34(4):481-6. PubMed ID: 17475427
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
11. Expression of p34cdc2 protein kinase and p53 in supraglottic carcinomas.
Yamamoto Y; Itoh T; Inoue I; Takahashi H
Auris Nasus Larynx; 1996; 23():105-10. PubMed ID: 8809331
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of phenotype of mononuclear host cells isolated from primary tumour and peripheral blood of patients with laryngeal carcinoma.
Zeromski J; Pietrzak J; Szmeja Z; Jezewska E; Górny MK; Kruk-Zagajewska A
Acta Otolaryngol; 1988; 105(1-2):149-54. PubMed ID: 3277340
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell subsets in neoplastic tissue and peripheral blood of laryngeal cancer patients: relation with grade and stage of the disease.
Klatka J; Grywalska E; Tabarkiewicz J; Polak A; Rolinski J
Oncol Rep; 2012 Jul; 28(1):207-17. PubMed ID: 22484550
[TBL] [Abstract][Full Text] [Related]
14. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Foxp3 and RORgamma t in peripheral blood mononuclear cells in patients with laryngeal carcinoma as indicators of tumor stage--preliminary study].
Papież P; Bryś M; Lewy-Trenda I; Stasikowska O; Woś J; Papierz W; Starska K
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):109-16. PubMed ID: 22000260
[TBL] [Abstract][Full Text] [Related]
16. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
17. Significance of ceramide and DNA ploidy in laryngeal carcinogenesis.
Yuan Y; Chi F; Wang S; Wang Z
ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):283-8. PubMed ID: 17565231
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene.
Shen Z; Zhan G; Deng H; Ren Y; Ye D; Xiao B; Guo J
J Laryngol Otol; 2013 Dec; 127(12):1194-202. PubMed ID: 24300127
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2 immunostaining in laryngeal cancer.
Krecicki T; Jeleń M; Zalesska-Krecicka M
Acta Otolaryngol; 1999; 119(3):392-5. PubMed ID: 10380748
[TBL] [Abstract][Full Text] [Related]
20. [DNA ploidy and DNA index in aneuploid laryngeal cancer].
Zatoński T; Krecicki T; Duś D; Zalesska-Krecicka M; Jeleń M
Pol Merkur Lekarski; 2004 Mar; 16(93):232-5. PubMed ID: 15190598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
